Presidents Xi Jinping and Donald Trump struck a friendly tone, the cybersecurity authority proposed thresholds for cross-border data assessments, China's largest-ever foreign deal cleared two major regulatory hurdles, and the CBRC highlighted 10 financial risks
China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
The CIRC's new draft regulations are set to change the landscape of investments in Chinese insurance companies中国保监会新发布的《保险公司股权管理办法(征求意见稿)》将改变中国保险公司的投资环境
In a rare move, the Texas judge rewrote the plea agreement to name his own independent corporate monitor in the ZTE sanctions case, substituting the DOJ's authority with the court's